Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

AgeX Therapeutics, Inc. (AGE) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/18/2023 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Granted 756,429 options to buy @ $0.661, valued at $500k
03/22/2023 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Gifted 16,447,500 shares @ $0
03/14/2023 4 WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,060 shares @ $0.59, valued at $625.4
Exercised 3,125 restricted stock units @ $0
02/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/13/2022 4 WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,081 shares @ $0.5623, valued at $607.8
Exercised 3,125 restricted stock units @ $0
08/24/2022 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Granted 746,380 options to buy @ $0.6699, valued at $500k
08/24/2022 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Granted 703,234 options to buy @ $0.711, valued at $500k
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2022 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Granted 568,440 options to buy @ $0.8796, valued at $500k
03/15/2022 4 WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,281 shares @ $0.6923, valued at $886.8
Exercised 3,125 restricted stock units @ $0
03/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2021 4 MALIK NAFEES NASEER (COO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $1.45, valued at $108.8k
03/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2020 4 WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,081 shares @ $1.69, valued at $1.8k
Exercised 3,125 restricted stock units @ $0
11/19/2020 4 Juvenescence Ltd (10% Owner) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Bought 280,898 options to buy @ $1.78, valued at $500k
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/15/2020 4 WEST MICHAEL D (CEO) has filed a Form 4 on AgeX Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,081 shares @ $0.8095, valued at $875.1
Exercised 3,125 restricted stock units @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy